Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

FRTX

Fresh Tracks Therapeutics (FRTX)

Fresh Tracks Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:FRTX
日付受信時刻ニュースソース見出しコード企業名
2024/06/0106 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/05/2406 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/05/2106 : 40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/05/0406 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/04/2406 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/04/1206 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/04/0606 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/04/0206 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/03/2206 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/03/1906 : 05Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/03/1605 : 09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/03/1406 : 23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/02/2307 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/02/1706 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/02/1503 : 04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/01/1806 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/01/1722 : 40Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/01/1206 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/01/1006 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/01/1006 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/01/0608 : 37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FRTXFresh Tracks Therapeutics Inc
2024/01/0607 : 15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:FRTXFresh Tracks Therapeutics Inc
2023/12/2823 : 00Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FRTXFresh Tracks Therapeutics Inc
2023/12/2822 : 58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FRTXFresh Tracks Therapeutics Inc
2023/12/2822 : 55Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FRTXFresh Tracks Therapeutics Inc
2023/12/2822 : 52Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FRTXFresh Tracks Therapeutics Inc
2023/12/2822 : 50Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FRTXFresh Tracks Therapeutics Inc
2023/12/2822 : 47Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FRTXFresh Tracks Therapeutics Inc
2023/12/2822 : 44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FRTXFresh Tracks Therapeutics Inc
2023/12/2822 : 41Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FRTXFresh Tracks Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FRTX

最近閲覧した銘柄

Delayed Upgrade Clock